Evidence map›Paper›PMID 39948343›Full record

ArticleScientific reports2025

LMNA R482L mutation causes impairments in C2C12 myoblasts subpopulations, alterations in metabolic reprogramming during differentiation, and oxidative stress.

Oksana A Ivanova, Alexander V Predeus, Margarita Y Sorokina, Elena V Ignatieva, Danila E Bobkov, Kseniia S Sukhareva, Anna A Kostareva, Renata I Dmitrieva

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Single-cell RNA profiling suggests goflikicept-mediated immune modulation in idiopathic recurrent pericarditis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Oksana A IvanovaResearch Centre for Personalized Medicine, Almazov National Medical Research Centre, 2 Akkuratova St., Saint Petersburg, 197341, Russia. oksana.ivanova.al@gmail.com.ORCID 0000-0002-6163-2162
Alexander V PredeusBioinformatics Institute, 2A Kantemirovskaya St., Saint Petersburg, 194100, Russia.
Margarita Y SorokinaResearch Centre for Personalized Medicine, Almazov National Medical Research Centre, 2 Akkuratova St., Saint Petersburg, 197341, Russia.
Elena V IgnatievaResearch Centre for Personalized Medicine, Almazov National Medical Research Centre, 2 Akkuratova St., Saint Petersburg, 197341, Russia.
Danila E BobkovResearch Centre for Personalized Medicine, Almazov National Medical Research Centre, 2 Akkuratova St., Saint Petersburg, 197341, Russia.
Kseniia S SukharevaResearch Centre for Personalized Medicine, Almazov National Medical Research Centre, 2 Akkuratova St., Saint Petersburg, 197341, Russia.
Anna A KostarevaResearch Centre for Personalized Medicine, Almazov National Medical Research Centre, 2 Akkuratova St., Saint Petersburg, 197341, Russia.
Renata I DmitrievaResearch Centre for Personalized Medicine, Almazov National Medical Research Centre, 2 Akkuratova St., Saint Petersburg, 197341, Russia. renata.i.dmitrieva@gmail.com.

Funding

Ministry of Science and Higher Education of the Russian Federation [Russia] No. 075-15-2022-301
6 · The paper itself

Abstract

LMNA mutations causing classical familial partial lipodystrophy of Dunnigan type (FPLD2) usually affect residue R482. FPLD is a severe metabolic disorder that often leads to cardiovascular and skeletal muscle complications. How LMNA mutations affect the functional properties of skeletal muscles is still not well understood. In the present project, we investigated the LMNA-R482L mutation-specific alterations in a transgenic mouse C2C12 cell line of myoblasts. Using single-cell RNA sequencing we have studied transcriptional diversity of cultured in vitro C2C12 cells. The LMNA-R482L mutation induces changes in C2C12 cluster composition and increases the expression of genes related to connective tissue development, oxidative stress, stress defense, and autophagy in a population-specific manner. Bulk RNA-seq confirmed these results and revealed the dysregulation of carbohydrate metabolism in differentiated R482L myotubes that was supported by ATP production profile evaluation. The measurement of reactive oxygen species (ROS) levels and glutathione accumulation in myoblasts and myotubes indicates R482L mutation-related dysregulation in mechanisms that control ROS production and scavenging through antioxidant glutathione system. The increased accumulation of autophagy-related structures in R482L myoblasts was also shown. Overall, our experiments showed a connection between the redox status and metabolic alterations with skeletal muscle pathological phenotypes in cells bearing pathogenic LMNA mutation.

Indexed as

Cell DifferentiationLamin Type ALipodystrophy, Familial PartialMutationMyoblastsOxidative StressAnimalsAutophagyCell LineMetabolic ReprogrammingMiceMice, TransgenicMuscle Fibers, SkeletalReactive Oxygen SpeciesLamin Type ALmna protein, mouseReactive Oxygen Species

Identifiers

PMID39948343
PMCPMC11825939

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.